Latest Schedule 13G passive stakes

Morgan Stanley and its subsidiary, Morgan Stanley Smith Barney LLC, have filed an updated Schedule 13G, reporting a combined beneficial ownership of 14.1% in BlackRock 2037 Municipal Target Term Trust.

Morgan Stanley and its subsidiary, Morgan Stanley Smith Barney LLC, have filed an updated Schedule 13G, reporting a combined beneficial ownership of 14.1% in BlackRock 2037 Municipal Target Term Trust.

Bank of Montreal and its affiliates have updated their beneficial ownership filings for OPENLANE, Inc., reporting a combined stake of 4.52%.

Bank of Montreal and its affiliates have updated their beneficial ownership filings for OPENLANE, Inc., reporting a combined stake of 4.52%.

GQG Partners LLC has reported a beneficial ownership of 4.8% of Atlassian Corporation's Class A Common Stock as of June 30, 2026.

Blue Owl Capital Holdings LP has disclosed beneficial ownership of 511,177 common shares, representing 0.76% of enGene Therapeutics Inc., acquired via warrants.

Bank of Montreal has updated its beneficial ownership filing for North American Construction Group Ltd., reporting a 5.05% stake as of June 30, 2026.

Bank of Montreal has updated its beneficial ownership filing for North American Construction Group Ltd., reporting a 5.05% stake as of June 30, 2026.

Jane Street Group, LLC and its affiliates have reported a significant beneficial ownership stake in Bitdeer Technologies Group, holding 5.7% of the Class A ordinary shares.

A group of entities affiliated with Morgan Stanley has reported beneficial ownership of 5,500,000 shares, representing 6.7% of the common stock of NN Inc.

A group of entities affiliated with Morgan Stanley has reported beneficial ownership of 5,500,000 shares, representing 6.7% of the common stock of NN Inc.

Jane Street Group, LLC and its affiliates have filed an amended Schedule 13G, reporting a combined beneficial ownership of 6.7% in AXT Inc. common stock as of June 30, 2026.

The Toronto-Dominion Bank and TD Securities Inc. have filed a Schedule 13G, reporting beneficial ownership of 6.9% of UroGen Pharma Ltd.'s ordinary shares.

The Toronto-Dominion Bank and TD Securities Inc. have filed a Schedule 13G, reporting beneficial ownership of 6.9% of UroGen Pharma Ltd.'s ordinary shares.

The Toronto-Dominion Bank and TD Securities Inc. have updated their beneficial ownership filing for Stoke Therapeutics, Inc., reporting a combined 4.9% stake.

The Toronto-Dominion Bank and TD Securities Inc. have updated their beneficial ownership filing for Stoke Therapeutics, Inc., reporting a combined 4.9% stake.

TD Securities (USA) LLC has reported a beneficial ownership of 773,603 Class A ordinary shares, representing 6.8% of the outstanding shares of Plutonian Acquisition Corp II.

TD Securities (USA) LLC has reported beneficial ownership of 2,263,847 Class A Ordinary Shares of MoneyHero Ltd, representing 6.8% of the class, exercisable through warrants.

TD Securities (USA) LLC and affiliated entities have filed a Schedule 13G, reporting zero beneficial ownership of GigCapital7 Corp. Class A ordinary shares.

Jane Street Group, LLC, along with its affiliates Jane Street Capital, LLC and Jane Street Global Trading, LLC, has filed a Schedule 13G, reporting beneficial ownership of 6.0% of Strive, Inc.'s Class A Common Stock.

TD entities, including TD Securities (USA) LLC, have filed a Schedule 13G indicating zero beneficial ownership of Cantor Equity Partners III, Inc. Class A ordinary shares.

TD entities, including TD Securities (USA) LLC and The Toronto-Dominion Bank, have filed an amended Schedule 13G, reporting their beneficial ownership of Cal Redwood Acquisition Corp. Class A Ordinary Shares.

Trigran Investments, Inc. and associated individuals have filed a Schedule 13G, disclosing a beneficial ownership of 4.8% of TechTarget, Inc.'s common stock as of June 30, 2026.

Morgan Stanley and Parametric Portfolio Associates LLC have jointly filed a Schedule 13G, reporting a combined beneficial ownership of 8.7% in Western Asset Emerging Markets Debt Fund Inc.

Morgan Stanley and Parametric Portfolio Associates LLC have jointly filed a Schedule 13G, reporting a combined beneficial ownership of 8.7% in Western Asset Emerging Markets Debt Fund Inc.

Morgan Stanley has filed a Schedule 13G amendment indicating its beneficial ownership of U.S. Physical Therapy Inc. common stock has fallen below the 5% threshold.

Morgan Stanley has filed a Schedule 13G amendment indicating its beneficial ownership of U.S. Physical Therapy Inc. common stock has fallen below the 5% threshold.

Morgan Stanley and its subsidiary, Morgan Stanley Investment Management Inc., have filed an amendment to their Schedule 13G, indicating they no longer beneficially own more than five percent of ProKidney Corp.'s Class A Common Stock.

Morgan Stanley and its subsidiary, Morgan Stanley Investment Management Inc., have filed an amendment to their Schedule 13G, indicating they no longer beneficially own more than five percent of ProKidney Corp.'s Class A Common Stock.

Morgan Stanley and Parametric Portfolio Associates LLC have jointly filed a Schedule 13G, reporting a combined beneficial ownership of 6.5% in NYLI CBRE Global Infrastructure Megatrends Term Fund.